Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity is a research paper published in Proceedings of the National Academy of Sciences (2025). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Wellcome Trust
Grant: 226615/Z/22/Z
UKRI | Medical Research Council
Grant: MR/S00971X/1
The Role Of Antibody in Enabling Cell-mediated Control of HCMV Infection
UKRI | Medical Research Council
Grant: MR/X000516/1
Novel mechanisms of necroptosis subversion by human cytomegalovirus
Wellcome Trust
Grant: 204870
Wellcome Trust
Grant: 108070/Z/15/Z
Wellcome Trust
Grant: 207503/Z/17/Z
NIAID NIH HHS
Grant: R01 AI186964
Wellcome Trust
Grant: 207503
The role of innate immune regulation in viral pathogenesis and the development of anti-viral T cell memory
UK Research and Innovation
Grant: MR/P001602/1
Systematic characterisation of the HCMV pathogenicity domain spontaneously lost from commonly used passaged strains
National Institutes of Health
Grant: 1R01AI186964-01
The role of cell, antigen, and antibody, in controlling virus infection through Fc-dependent mechanisms
Wellcome Trust
Grant: 226615
Exploiting Novel Antiviral Immune Responses
Wellcome Trust
Grant: 108070
Functional proteomic analysis of innate immune subversion by human cytomegalovirus.
UK Research and Innovation
Grant: MR/L008734/1
Utilising proteomics to develop anti-HCMV immunotherapy
UK Research and Innovation
Grant: MR/V000489/1
Characterisation of a novel class of natural killer cell immunoevasin
Wellcome Trust
Fields of Study
MeSH Terms
Keywords
Predicted structural models of HCMV gH in complex with partners gpUL141 or gpUL116, and gB in complex with gpUL141